These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7958544)

  • 21. Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state.
    Fanelli CG; Pampanelli S; Porcellati F; Bartocci L; Scionti L; Rossetti P; Bolli GB
    Diabetologia; 2003 Jan; 46(1):53-64. PubMed ID: 12637983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM.
    Davis MR; Mellman M; Shamoon H
    Diabetes; 1992 Oct; 41(10):1335-40. PubMed ID: 1397708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM.
    Kolterman OG; Schwartz S; Corder C; Levy B; Klaff L; Peterson J; Gottlieb A
    Diabetologia; 1996 Apr; 39(4):492-9. PubMed ID: 8778001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs.
    Plum A; Agerso H; Andersen L
    Drug Metab Dispos; 2000 Feb; 28(2):155-60. PubMed ID: 10640512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective free-fatty acid and oxidative glucose metabolism in IDDM during hypoglycemia. Influence of glycemic control.
    Caprio S; Amiel S; Tamborlane WV; Gelfand RA; Sherwin RS
    Diabetes; 1990 Feb; 39(2):134-41. PubMed ID: 2227120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal activity profiles of NPH and [Nepsilon-palmitoyl Lys (B29)] human insulins in subjects with IDDM.
    Radziuk J; Pye S; Bradley B; Braaten J; Vignati L; Roach P; Bowsher R; DiMarchi R; Chance R
    Diabetologia; 1998 Jan; 41(1):116-20. PubMed ID: 9498640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
    Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
    Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM.
    Bolinder J; Sjöberg S; Arner P
    Diabetologia; 1996 Jul; 39(7):845-53. PubMed ID: 8817110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substrate availability other than glucose in the brain during euglycemia and insulin-induced hypoglycemia in dogs.
    Avogaro A; Nosadini R; Doria A; Tremolada C; Baccaglini U; Ambrosio F; Merkel C; Nosadini A; Trevisan R; Fioretto P
    Metabolism; 1990 Jan; 39(1):46-50. PubMed ID: 2403619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in pharmacokinetics and pharmacodynamics of insulin lispro and aspart in healthy volunteers.
    von Mach MA; Brinkmann C; Hansen T; Weilemann LS; Beyer J
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):416-9. PubMed ID: 12518253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose turnover and gluconeogenesis during pregnancy in women with and without insulin-dependent diabetes mellitus.
    Chiasson JL; el Achkar GG; Ducros F; Bourque J; Maheux P
    Clin Invest Med; 1997 Jun; 20(3):140-51. PubMed ID: 9189645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologic hyperinsulinemia enhances counterregulatory hormone responses to hypoglycemia in IDDM.
    Davis MR; Mellman M; Shamoon H
    J Clin Endocrinol Metab; 1993 May; 76(5):1383-5. PubMed ID: 8496333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of activated glucose counterregulation on insulin requirements in insulin-dependent diabetes mellitus.
    Bolli GB; Perriello G
    Horm Metab Res Suppl; 1990; 24():87-96. PubMed ID: 2272633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
    Roach P; Woodworth JR
    Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
    Ahmed AB; Home PD
    Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lys(B28), Pro(B29)]-human insulin: effect of injection time on postprandial glycemia.
    Howey DC; Bowsher RR; Brunelle RL; Rowe HM; Santa PF; Downing-Shelton J; Woodworth JR
    Clin Pharmacol Ther; 1995 Oct; 58(4):459-69. PubMed ID: 7586939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
    Peacey SR; George E; Rostami-Hodjegan A; Bedford C; Harris N; Hardisty CA; Tucker GT; Macdonald IA; Heller SR
    Diabet Med; 1996 Jul; 13(7):634-41. PubMed ID: 8840097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of near physiologic insulin therapy on hypoglycemia counterregulation in type-1 diabetes.
    Bischof MG; Bernroider E; Ludwig C; Kurzemann S; Kletter K; Waldhäusl W; Roden M
    Horm Res; 2001; 56(5-6):151-8. PubMed ID: 11910200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.